WntResearch: The lead project Foxy-5 has now been earmarked for funding from the Eurostars program

The Eurostars programme funds research and development (R&D) activities driven by Small and Medium size Entities. The EU is supporting the initiative with a €100 million grant, while an additional €300 million will come from the 27 countries which have signed up to the initiative.


VD Nils Brünner comments:
The funding is a financial break through for WntResearch and we are all eager to execute the strategy for the development of Foxy-5 as an anti-metastatic drug. I feel confident that with the present international Eurostars consortium, the competences of the Board of Directors and Management we have the ideal team for being successful. I acknowledge the foresight of Bert Junno, former CEO now CFO for having applied for the Eurostars funding.


For further information please contact:

Nils Brünner, CEO
E-mail: nbr@wntresearch.com
Telephone: +45 2614 4708

or

Peter Buhl Jensen, Chairman of the Board
E-mail: pbj@buhloncology.com
Telephone: +45 2160 8922


View news item from WntResearch: //WWW03/Press/Wntresearch/60920/WntResearch_WNT_20120201_9.pdf